AIDS Treatment News logo      

October 21, 2009

Etravirine, darunavir/ritonavir and raltegravir very effective in highly treatment-experienced patients

"A combination of raltegravir, etravirine and darunavir/ritonavir is highly effective at suppressing viral load to undetectable levels in treatment-experienced patients, French investigators report in the November 1st edition of Clinical Infectious Diseases.

"All 100 patients in the 48-week, prospective, non-comparator study had multiple resistance mutations to protease inhibitors and nucleoside reverse transcriptase inhibitors (NRTIs). Nevertheless, after a year of treatment with the three new drugs, 86% had a viral load below 50 copies/ml."

Read more in Aidsmap, October 19, 2009.